Polen Capital acquired 30.9 Thousand Repligen shares worth $3.84 Million. That's 0.01% of their equity portfolio (68th largest holding). Polen Capital started to build up the position in Repligen in Q2 2024 and continued to invest until Q4 2024. Since then they sold 9.65 Thousand shares. The investor's estimated purchase price is $4.58 Million, resulting in a loss of 16%.
Conestoga Capital Advisors, an asset management company, released its “SMid Cap Growth Strategy” third-quarter 2023 investor letter. A copy of the same can b...
https://www.investing.com/news/pro/repligen-corp-receives-investment-bank-analyst-rating-update-3120648
Pulled from Benzinga Pro data, Repligen (NASDAQ: RGEN ) posted Q1 earnings of $28.83 million, an increase from Q4 of 40.84%. Sales dropped to $182.66 million...
https://www.investing.com/news/pro/rbc-capital-starts-repligen-at-sector-perform-432SI-2958584